OIG: Drugmakers should disclose wholesale prices to CMS

04/27/2011 | Hill, The

Medicare could save $4.4 million each year by reducing reimbursement for drugs covered under Part B that have an average sale price at least 5% more than the wholesale price, according to an HHS Inspector General's report. The CMS responded by saying doing so would violate a court order against disclosing wholesale prices to the public.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX